Amedeo Smart

Free Medical Literature Service

 

Amedeo

Arrhythmias
  Free Subscription

Articles published in
Ann Intern Med
    March 2024
  1. SHADRIN IY, Newby LK
    In subclinical AF, apixaban reduced stroke or systemic embolism but increased major bleeding vs. aspirin at 3.5 y.
    Ann Intern Med. 2024;177:JC26.
    >> Share

    January 2024
  2. ISHIGUCHI H, Lip GYH
    In symptomatic AF, catheter ablation vs. medical therapy reduced depression and anxiety symptoms at 12 mo.
    Ann Intern Med. 2024 Jan 2. doi: 10.7326/J23-0105.
    >> Share

  3. LOPEZ J, Borzak S
    In noncardiac thoracic surgery, low-dose colchicine did not reduce AF or myocardial injury after noncardiac surgery at 14 d.
    Ann Intern Med. 2024;177:JC3.
    >> Share

    December 2023
  4. BROPHY J
    In symptomatic AF with end-stage HF, adding catheter ablation to medical therapy improved clinical outcomes at 18 mo.
    Ann Intern Med. 2023;176:JC137.
    >> Share

    October 2023
  5. MCINTYRE WF, Vadakken ME, Connolly SJ, Mendoza PA, et al
    Atrial Fibrillation Recurrence in Patients With Transient New-Onset Atrial Fibrillation Detected During Hospitalization for Noncardiac Surgery or Medical Illness : A Matched Cohort Study.
    Ann Intern Med. 2023 Oct 3. doi: 10.7326/M23-1411.
    >> Share

  6. BARNES GD
    In adults, MRAs reduce AF occurrence vs. non-MRAs.
    Ann Intern Med. 2023;176:JC114.
    >> Share

    September 2023
  7. TON IT, Moon J, Sengul A, Mody FV, et al
    Evidence-Based Cardiovascular Disease Medicines' Availability in Low-Cost Generic Drug Programs in the United States : A Cross-Sectional Study.
    Ann Intern Med. 2023 Sep 5. doi: 10.7326/M23-0287.
    >> Share

    August 2023

  8. Correction: Atrial Fibrillation.
    Ann Intern Med. 2023 Aug 15. doi: 10.7326/L23-0291.
    >> Share

  9. CARLIN S, Douketis J
    In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level.
    Ann Intern Med. 2023 Aug 1. doi: 10.7326/J23-0054.
    >> Share

    July 2023

  10. Correction: Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease.
    Ann Intern Med. 2023 Jul 25. doi: 10.7326/L23-0266.
    >> Share

  11. AL-KHATIB SM
    Atrial Fibrillation.
    Ann Intern Med. 2023;176:ITC97-ITC112.
    >> Share

    June 2023
  12. ALBERTS MJ
    After ICH, starting long-term therapeutic oral anticoagulation in patients with AF reduces MACE at 1 to 3 y.
    Ann Intern Med. 2023;176:JC71.
    >> Share

    May 2023
  13. RAY WA, Chung CP, Stein CM, Smalley W, et al
    Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation : A Retrospective Cohort Study.
    Ann Intern Med. 2023 May 23. doi: 10.7326/M22-3238.
    >> Share

  14. JOUNG B, Kim D, Yang PS, Sung JH, et al
    Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients.
    Ann Intern Med. 2023;176:eL220502.
    >> Share

  15. QIU M, Du L
    Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients.
    Ann Intern Med. 2023;176:eL220501.
    >> Share

    March 2023
  16. CHEW DS, Piccini JP
    Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation.
    Ann Intern Med. 2023;176:eL220517.
    >> Share

  17. ANDERSON CE, Lieberman RA, Olshansky B
    Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation.
    Ann Intern Med. 2023;176:eL220516.
    >> Share

  18. TAN NS
    In symptomatic AF, cryoballoon ablation reduced progression to persistent AF vs. antiarrhythmic therapy at 3 y.
    Ann Intern Med. 2023;176:JC29.
    >> Share

  19. DUNN A
    In AF, underdosing of DOACs was not linked to reduced bleeding.
    Ann Intern Med. 2023;176:JC32.
    >> Share

  20. RA J, Oberdier MT, Suzuki M, Vaidya D, et al
    Implantable Defibrillator System Shock Function, Mortality, and Cause of Death After Magnetic Resonance Imaging.
    Ann Intern Med. 2023;176:289-297.
    >> Share

    January 2023
  21. CENTOR RM, Doppalapudi H
    Annals On Call - Atrial Fibrillation: Control Rate or Rhythm?
    Ann Intern Med. 2023 Jan 3:eA220001. doi: 10.7326/A22-0001.
    >> Share

  22. LADER EW
    In rheumatic heart disease-associated AF, rivaroxaban increased adverse vascular outcomes vs. VKA at 3 y.
    Ann Intern Med. 2023;176:JC2.
    >> Share

  23. GULATI S, Eckman MH
    Anticoagulant Therapy for Cancer-Associated Thrombosis : A Cost-Effectiveness Analysis.
    Ann Intern Med. 2023;176:1-9.
    >> Share

    December 2022
  24. MAHESHWARI A, Norby FL, Inciardi RM, Wang W, et al
    Left Atrial Mechanical Dysfunction and the Risk for Ischemic Stroke in People Without Prevalent Atrial Fibrillation or Stroke : A Prospective Cohort Study.
    Ann Intern Med. 2022 Dec 20. doi: 10.7326/M22-1638.
    >> Share

  25. KO D, Benjamin EJ
    Atrial Cardiopathy and Cardioembolic Stroke.
    Ann Intern Med. 2022 Dec 20. doi: 10.7326/M22-3476.
    >> Share


  26. Correction: Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation.
    Ann Intern Med. 2022 Dec 6. doi: 10.7326/L22-0482.
    >> Share

  27. WEITZ HH, Merli GJ, Siontis K
    Web Exclusive. Annals Consult Guys - Postoperative Atrial Fibrillation.
    Ann Intern Med. 2022;175:CG1.
    >> Share

    November 2022
  28. HEALEY JS, Krahn AD, Bashir J, Amit G, et al
    Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations : A Randomized, Multicenter Trial.
    Ann Intern Med. 2022 Nov 8. doi: 10.7326/M22-1566.
    >> Share

  29. LAU WCY, Torre CO, Man KKC, Stewart HM, et al
    Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation : A Multinational Population-Based Cohort Study.
    Ann Intern Med. 2022 Nov 1. doi: 10.7326/M22-0511.
    >> Share


  30. Correction: Risk for Recurrent Venous Thromboembolism and Bleeding With Apixaban Compared With Rivaroxaban and Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation.
    Ann Intern Med. 2022;175:1627-1628.
    >> Share

    October 2022
  31. DAWWAS GK, Cuker A, Barnes GD, Lewis JD, et al
    Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease : A Population-Based Study.
    Ann Intern Med. 2022 Oct 18. doi: 10.7326/M22-0318.
    >> Share

    September 2022
  32. KIM D, Yang PS, You SC, Jang E, et al
    Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients : A Nationwide Propensity Score-Weighted Study.
    Ann Intern Med. 2022 Sep 6. doi: 10.7326/M21-4798.
    >> Share

    August 2022
  33. CHEW DS, Zhou K, Pokorney SD, Matchar DB, et al
    Left Atrial Appendage Occlusion Versus Oral Anticoagulation in Atrial Fibrillation : A Decision Analysis.
    Ann Intern Med. 2022 Aug 16. doi: 10.7326/M21-4653.
    >> Share

  34. KANTHARIA BK
    Left Atrial Appendage Occlusion Versus Anticoagulation in Atrial Fibrillation: Equipoise When Bleeding Risk Is High.
    Ann Intern Med. 2022 Aug 16. doi: 10.7326/M22-2271.
    >> Share


  35. Summary for Patients: Occlusion Devices Versus Blood Thinners for Atrial Fibrillation.
    Ann Intern Med. 2022 Aug 16. doi: 10.7326/P22-0015.
    >> Share

    July 2022
  36. SIONTIS KC, Gersh BJ, Weston SA, Jiang R, et al
    Associations of Atrial Fibrillation After Noncardiac Surgery With Stroke, Subsequent Arrhythmia, and Death : A Cohort Study.
    Ann Intern Med. 2022 Jul 26. doi: 10.7326/M22-0434.
    >> Share

  37. ALMHRI A, Leong DP
    In AF, CV benefits of catheter ablation vs. medical therapy may vary by age.
    Ann Intern Med. 2022;175:JC77.
    >> Share

    June 2022
  38. CHOI SE, Lip GYH
    USPSTF found insufficient evidence on the benefits and harms of screening adults >/=50 y for AF.
    Ann Intern Med. 2022;175:JC62.
    >> Share

    February 2022
  39. HUANG HK, Liu PP, Lin SM, Hsu JY, et al
    Diabetes-Related Complications and Mortality in Patients With Atrial Fibrillation Receiving Different Oral Anticoagulants : A Nationwide Analysis.
    Ann Intern Med. 2022 Feb 15. doi: 10.7326/M21-3498.
    >> Share

  40. COLIVICCHI F
    In AF after TAVR, edoxaban was noninferior to VKAs for a composite of adverse events but increased major bleeding.
    Ann Intern Med. 2022;175:JC22.
    >> Share

  41. SANTULLI G, Mone P
    In permanent AF with narrow QRS, AV junction ablation + CRT vs. rate-control drug therapy reduced mortality.
    Ann Intern Med. 2022;175:JC21.
    >> Share

    January 2022
  42. YOUSUFUDDIN M, Jahangir A
    In older patients at high risk for stroke, intensive AF screening with an implantable loop recorder did not reduce stroke.
    Ann Intern Med. 2022;175:JC8.
    >> Share

  43. YOUSUFUDDIN M, Jahangir A
    In adults aged 75 to 76 y, systematic AF screening reduced morbidity and mortality at 6 y.
    Ann Intern Med. 2022;175:JC9.
    >> Share

    December 2021
  44. WILLETT LR, Kim S
    In paroxysmal AF, first-line catheter ablation vs. antiarrhythmic drugs reduces atrial arrhythmia recurrence.
    Ann Intern Med. 2021 Dec 7. doi: 10.7326/ACPJ202112210.
    >> Share

    October 2021
  45. SHAH S, Garg J
    Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation.
    Ann Intern Med. 2021;174:1489-1490.
    >> Share

  46. DAWWAS GK, Barnes GD, Cuker A, Lewis JD, et al
    Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation.
    Ann Intern Med. 2021;174:1490.
    >> Share

  47. RODWIN BA
    Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation.
    Ann Intern Med. 2021;174:1488-1489.
    >> Share

  48. MANSI IA, Bhushan S, Albracht DE
    Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation.
    Ann Intern Med. 2021;174:1489.
    >> Share

    September 2021
  49. SAMPSON C
    In acute atrial flutter, adding pharmacologic before electrical cardioversion did not increase conversion to normal sinus rhythm.
    Ann Intern Med. 2021 Sep 7. doi: 10.7326/ACPJ202109210.
    >> Share

    August 2021
  50. PIANO MR, Hwang CL
    Holiday Heart Confirmed: Alcohol-Associated Atrial Fibrillation.
    Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-3193.
    >> Share


  51. Summary for Patients: Alcohol Drinking and Atrial Fibrillation.
    Ann Intern Med. 2021 Aug 31. doi: 10.7326/P21-0008.
    >> Share

  52. MARCUS GM, Vittinghoff E, Whitman IR, Joyce S, et al
    Acute Consumption of Alcohol and Discrete Atrial Fibrillation Events.
    Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-0228.
    >> Share

    July 2021
  53. KIM DH, Pawar A, Gagne JJ, Bessette LG, et al
    Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation : A Cohort Study.
    Ann Intern Med. 2021 Jul 20. doi: 10.7326/M20-7141.
    >> Share

    June 2021
  54. KARIMZAD K, Deswal A
    In older patients with permanent AF and HF, digoxin and bisoprolol did not differ for QoL at 6 mo.
    Ann Intern Med. 2021;174:JC69.
    >> Share

    April 2021
  55. GUE YX, Lip GYH
    In patients with AF and a bioprosthetic mitral valve, rivaroxaban was noninferior to warfarin for time to clinical events.
    Ann Intern Med. 2021;174:JC43.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016